Selected research
Market Outlook & Growth Opportunities
Global Brilinta Market Outlook and Growth Opportunities 2026
Market perspective
The global Brilinta market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Brilinta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Brilinta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Brilinta is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Brilinta market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Brilinta market include Astrazeneca. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Brilinta market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Brilinta and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Brilinta sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brilinta market size, projected growth trends, production technologies, key applications, and end-use industries.
Brilinta Segment by Company
Astrazeneca
Brilinta Segment by Type
90 mg Tablet
60 mg Tablet
Brilinta Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Brilinta Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Brilinta status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Brilinta market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Brilinta significant trends, drivers, influence factors in global and regions.
6. To analyze Brilinta competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brilinta market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Brilinta and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brilinta.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Brilinta market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brilinta industry.
Chapter 3: Detailed analysis of Brilinta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Brilinta in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Brilinta in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- 90 mg Tablet
- 60 mg Tablet
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Astrazeneca
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Brilinta Sales Value (2021-2032)
- 1.2.2 Global Brilinta Sales Volume (2021-2032)
- 1.2.3 Global Brilinta Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 Brilinta Market Dynamics
- 2.1 Brilinta Industry Trends
- 2.2 Brilinta Industry Drivers
- 2.3 Brilinta Industry Opportunities and Challenges
- 2.4 Brilinta Industry Restraints
3 Brilinta Market by Company
- 3.1 Global Brilinta Company Revenue Ranking in 2025
- 3.2 Global Brilinta Revenue by Company (2021-2026)
- 3.3 Global Brilinta Sales Volume by Company (2021-2026)
- 3.4 Global Brilinta Average Price by Company (2021-2026)
- 3.5 Global Brilinta Company Ranking (2024-2026)
- 3.6 Global Brilinta Company Manufacturing Base and Headquarters
- 3.7 Global Brilinta Company Product Type and Application
- 3.8 Global Brilinta Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global Brilinta Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 Brilinta Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 Brilinta Market by Type
- 4.1 Brilinta Type Introduction
- 4.1.1 90 mg Tablet
- 4.1.2 60 mg Tablet
- 4.2 Global Brilinta Sales Volume by Type
- 4.2.1 Global Brilinta Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Brilinta Sales Volume by Type (2021-2032)
- 4.2.3 Global Brilinta Sales Volume Share by Type (2021-2032)
- 4.3 Global Brilinta Sales Value by Type
- 4.3.1 Global Brilinta Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Brilinta Sales Value by Type (2021-2032)
- 4.3.3 Global Brilinta Sales Value Share by Type (2021-2032)
5 Brilinta Market by Application
- 5.1 Brilinta Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Online Pharmacies
- 5.1.3 Retail Pharmacies
- 5.2 Global Brilinta Sales Volume by Application
- 5.2.1 Global Brilinta Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Brilinta Sales Volume by Application (2021-2032)
- 5.2.3 Global Brilinta Sales Volume Share by Application (2021-2032)
- 5.3 Global Brilinta Sales Value by Application
- 5.3.1 Global Brilinta Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Brilinta Sales Value by Application (2021-2032)
- 5.3.3 Global Brilinta Sales Value Share by Application (2021-2032)
6 Brilinta Regional Sales and Value Analysis
- 6.1 Global Brilinta Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Brilinta Sales by Region (2021-2032)
- 6.2.1 Global Brilinta Sales by Region: 2021-2026
- 6.2.2 Global Brilinta Sales by Region (2027-2032)
- 6.3 Global Brilinta Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global Brilinta Sales Value by Region (2021-2032)
- 6.4.1 Global Brilinta Sales Value by Region: 2021-2026
- 6.4.2 Global Brilinta Sales Value by Region (2027-2032)
- 6.5 Global Brilinta Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America Brilinta Sales Value (2021-2032)
- 6.6.2 North America Brilinta Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe Brilinta Sales Value (2021-2032)
- 6.7.2 Europe Brilinta Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific Brilinta Sales Value (2021-2032)
- 6.8.2 Asia-Pacific Brilinta Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America Brilinta Sales Value (2021-2032)
- 6.9.2 South America Brilinta Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa Brilinta Sales Value (2021-2032)
- 6.10.2 Middle East & Africa Brilinta Sales Value Share by Country, 2025 VS 2032
7 Brilinta Country-level Sales and Value Analysis
- 7.1 Global Brilinta Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global Brilinta Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global Brilinta Sales by Country (2021-2032)
- 7.3.1 Global Brilinta Sales by Country (2021-2026)
- 7.3.2 Global Brilinta Sales by Country (2027-2032)
- 7.4 Global Brilinta Sales Value by Country (2021-2032)
- 7.4.1 Global Brilinta Sales Value by Country (2021-2026)
- 7.4.2 Global Brilinta Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA Brilinta Sales Value Growth Rate (2021-2032)
- 7.5.2 USA Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada Brilinta Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico Brilinta Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany Brilinta Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France Brilinta Sales Value Growth Rate (2021-2032)
- 7.9.2 France Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. Brilinta Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy Brilinta Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain Brilinta Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia Brilinta Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands Brilinta Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries Brilinta Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China Brilinta Sales Value Growth Rate (2021-2032)
- 7.16.2 China Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan Brilinta Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea Brilinta Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India Brilinta Sales Value Growth Rate (2021-2032)
- 7.19.2 India Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia Brilinta Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia Brilinta Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil Brilinta Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina Brilinta Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile Brilinta Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia Brilinta Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru Brilinta Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia Brilinta Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel Brilinta Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE Brilinta Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey Brilinta Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran Brilinta Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran Brilinta Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt Brilinta Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt Brilinta Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt Brilinta Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Astrazeneca
- 8.1.1 Astrazeneca Company Information
- 8.1.2 Astrazeneca Business Overview
- 8.1.3 Astrazeneca Brilinta Sales, Value and Gross Margin (2021-2026)
- 8.1.4 Astrazeneca Brilinta Product Portfolio
- 8.1.5 Astrazeneca Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Brilinta Value Chain Analysis
- 9.1.1 Brilinta Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Brilinta Sales Mode & Process
- 9.2 Brilinta Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Brilinta Distributors
- 9.2.3 Brilinta Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst